Increased level of HSP27 but not of HSP72 in human heart allografts in relation to acute rejection

Transplantation. 2000 Dec 27;70(12):1694-7. doi: 10.1097/00007890-200012270-00005.

Abstract

Background: Increased expression of heat shock proteins (HSPs) was assumed during cardiac allograft rejection. To find evidence for this in man, we quantified HSP27 and HSP72 in cardiac allograft biopsies.

Methods: In parallel to histological assessment of rejection, HSP27 was quantified by Western blotting in a total of 43 biopsies sampled from 3 patients. HSP72 was analyzed in parallel in 30 of the 43 cases. For comparison, HSPs were analyzed in myocardium.

Results: HSP27 was significantly higher in rejecting cardiac allografts than in non-rejecting allografts and non-failing myocardium (1.52 +/- 0.25 vs. 0.83 +/- 0.11 vs. 0.50 +/- 0.05 microg/mg protein). Similarity for HSP72 (6.27 +/- 1.54 vs. 4.06 +/- 1.03 vs. 6.27 +/- 0.76 microg/mg protein) was not found.

Conclusion: For the first time in humans with cardiac allograft rejection, increased expression of HSP27, which could be important for cardiac self-protection, was demonstrated. For the lack of increased HSP72 expression, the influence of the cyclosporine A treatment was discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Cyclosporine / pharmacology
  • Graft Rejection / etiology
  • Graft Rejection / metabolism*
  • HSP27 Heat-Shock Proteins
  • HSP72 Heat-Shock Proteins
  • Heart Transplantation / adverse effects
  • Heart Transplantation / physiology*
  • Heat-Shock Proteins / metabolism*
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Microscopy, Fluorescence
  • Molecular Chaperones
  • Myocardium / metabolism
  • Neoplasm Proteins / metabolism*
  • Transplantation, Homologous

Substances

  • HSP27 Heat-Shock Proteins
  • HSP72 Heat-Shock Proteins
  • HSPB1 protein, human
  • Heat-Shock Proteins
  • Immunosuppressive Agents
  • Molecular Chaperones
  • Neoplasm Proteins
  • Cyclosporine